As Orange County's only academic health system, UCI Health has the expertise and resources to provide state-of-the-art care for patients with amyloidosis, a little-understood disorder often mistaken for other conditions.

Led by UCI Health cardiologist Dr. Roxana Ghashghaei, who also has expertise in echocardiography and nuclear medicine, we apply the latest clinical advances, cardiac imaging and testing technologies to develop a comprehensive diagnosis and treatment plan for cardiac amyloidosis.

Working with our network of UCI Health cardiologists, nephrologists, neurologists, hematologists/oncologists and gastrointestinal specialists, we also are uniquely able to deliver treatment across multiple disciplines, providing each patient with a personalized approach to care.

Diagnosis

A diagnosis of cardiac amyloidosis is often delayed because early symptoms may suggest heart failure. These include: 

Treatment

Medication to stabilize the proteins and prevent further progression of amyloid deposits. 

To learn more about amyloidosis, visit:

• National Organization for Rare Disorders (NORD)
• Amyloidosis Foundation
• Amyloidosis Research Consortium
• Amyloidosis Support Groups
• International Society of Amyloidosis

Our experienced cardiologists work with a highly skilled, multidisciplinary team to provide you with the best possible care.

Our team includes:

Cardiology

• Roxana Ghashghaei, MD
• Behram P. Mody, MD

Hematology-Oncology

• Lisa X. Lee, MD
• Zahra Pakbaz, MD

Nephrology

• Rebecca S. Ahdoot, MD

Neurology

• Ali A. Habib, MD
• Manisha K. Korb, MD
  

Orthopedics

• Gregory H. Rafijah, MD